Eden Brew, an Australian company, has had its application for assessment of its non-animal Beta-Casein Protein Preparation (BCPP1) accepted by Food Standards Australia New Zealand (FSANZ). BCPP1 is a nutritional and functional ingredient that can be used as a substitute for conventional dairy or plant proteins in various foods and is said to be nutritionally equivalent to A2 beta-casein found in cow's milk. This ingredient is reportedly the first precision-fermented milk protein to enter the Australian regulatory framework, and the assessment process by FSANZ is expected to take about a year, with a public consultation scheduled for April to May 2026.

The company hopes that the successful application could open up opportunities for future novel food proteins in Australia and New Zealand. Eden Brew has already secured $24.4 million in Series A funding in 2023 for the development of animal-free casein proteins. The company expressed pride in reaching this milestone, highlighting the significant scientific work and safety data that went into the submission. They credited their team, advisors, partners, investors, and community for supporting their vision of creating the next generation of functional nutrition.